One reported 23 patients who were treated neoadjuvantly and found a statistically significant association between the presence of ERβ2/βcx and response to tamoxifen (P=0.04) but the group was unusual in that all three ERα-negative tumours also responded to treatment. Here, ERAL1 is linked to neoplasm.